3 ms·
Startups often avoid Bio and Pharma because of how slow the big partners can be. Would be great to see other Pharma companies restructuring in similar way - rev
by ashvardanian 3y ago
Startups often avoid Bio and Pharma because of how slow the big partners can be. Would be great to see other Pharma companies restructuring in similar way - reviving the sector and attracting startups and new technologies.